An update on zolpidem abuse and dependence

Area of Science:

• Pharmacology
• Clinical Pharmacy
• Drug Safety

Background:

• The French National Agency for Medicines and Health Products Safety (ANSM) updated zolpidem's drug characteristics in 2004 to include potential pharmacodependence.
• This study investigates whether this regulatory change effectively addressed zolpidem's association with problematic drug use.

Observation:

• A review of postmarketing data from France's Addictovigilance network (2003-2010) and 30 literature case reports was conducted.
• Data were analyzed to assess the abuse and dependence potential of zolpidem.

Findings:

• Postmarketing surveillance and literature review data indicate a significant potential for zolpidem abuse and dependence.
• Despite the 2004 modification, zolpidem continues to be associated with problematic drug use patterns.

Implications:

• The findings suggest that current regulations may be insufficient to mitigate zolpidem's abuse potential.
• Stronger regulatory measures in France are proposed to address the identified risks of zolpidem dependence and abuse.